INMUNEBIO

inmunebio-logo

INmune Bio is a clinical-stage immuno-oncology company focused on harnessing the patientโ€™s immune system to treat cancer. INKmune, the companyโ€™s lead product, primes patientโ€™s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cellsโ€™ ability to eliminate residual disease.

#SimilarOrganizations #People #Financial #Website #More

INMUNEBIO

Social Links:

Industry:
Biotechnology Commercial Industrial Medical

Founded:
2015-01-01

Address:
La Jolla, California, United States

Country:
United States

Website Url:
http://www.inmunebio.com

Total Employee:
11+

Status:
Active

Contact:
(858) 964 3720

Email Addresses:
[email protected]

Total Funding:
103.21 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Font Awesome Apache Mobile Non Scaleable Content


Similar Organizations

advaxis-logo

Advaxis

Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.

bkm-capital-partners-logo

bkm Capital Partners

A fund manager specializing in the acquisition and improvement of value-add multi-tenant industrial properties across the Western U.S.

cyteir-therapeutics-logo

Cyteir Therapeutics

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

evo-group-logo

EVO Group

EVO Group is specialist multi-channel distributor of business supplies and services.

ngm-biopharmaceuticals-logo

NGM Biopharmaceuticals

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

sequre-dx-logo

SeQure DX

SeQure DX is in the business activities at non-commercial site business.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

stipe-therapeutics-logo

STipe Therapeutics

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.


Current Advisors List

david-szymkowski_image

David Szymkowski Board Member @ INmuneBIO
Board_member

j-kelly-ganjei_image

J. Kelly Ganjei Board Member @ INmuneBIO
Board_member
2016-09-01

raymond-j-tesi_image

Raymond J. Tesi Board Chairman @ INmuneBIO
Board_member
2015-09-01

timothy-schroeder_image

Timothy Schroeder Board Member @ INmuneBIO
Board_member
2016-12-01

scott-juda_image

Scott Juda Board Member @ INmuneBIO
Board_member
2018-03-01

Current Employees Featured

david-j-moss_image

David J. Moss
David J. Moss CFO @ INmuneBIO
CFO

raymond-j-tesi_image

Raymond J. Tesi
Raymond J. Tesi President , CEO & CMO @ INmuneBIO
President , CEO & CMO
2015-09-01

mark-lowdell_image

Mark Lowdell
Mark Lowdell CSO, Founder & CMO @ INmuneBIO
CSO, Founder & CMO
2016-05-01

Founder


david-j-moss_image

David J. Moss

mark-lowdell_image

Mark Lowdell

raymond-j-tesi_image

Raymond J. Tesi

Stock Details


Company's stock symbol is NASDAQ:INMB

Investors List

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - INmuneBIO

toucan-capital_image

Toucan Capital

Toucan Capital investment in Post-IPO Equity - INmuneBIO

alector_image

Alector

Alector investment in Post-IPO Equity - INmuneBIO

Official Site Inspections

http://www.inmunebio.com Semrush global rank: 4.62 M Semrush visits lastest month: 2.18 K

  • Host name: 104.21.83.67
  • IP address: 104.21.83.67
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "INmuneBIO" on Search Engine